Cargando…
A Novel Drug Design Strategy: An Inspiration from Encaging Tumor by Metallofullerenol Gd@C(82)(OH)(22)
Cancer remains a major threat to human health worldwide. Cytotoxicity has imposed restrictions on the conventional cytotoxic drug-based chemotherapy. The rapidly-developing nanomedicine has shown great promise in revolutionizing chemotherapy with improved efficiency and reduced toxicity. Gd@C(82)(OH...
Autores principales: | Li, Jinxia, Chen, Linlin, Yan, Liang, Gu, Zhanjun, Chen, Zhaofang, Zhang, Aiping, Zhao, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650816/ https://www.ncbi.nlm.nih.gov/pubmed/31252662 http://dx.doi.org/10.3390/molecules24132387 |
Ejemplares similares
-
Non-destructive Inhibition of Metallofullerenol Gd@C(82)(OH)(22) on WW domain: Implication on Signal Transduction Pathway
por: Kang, Seung-gu, et al.
Publicado: (2012) -
Dual Inhibitory Pathways of Metallofullerenol Gd@C(82)(OH)(22) on Matrix Metalloproteinase-2: Molecular insight into drug-like nanomedicine
por: Kang, Seung-gu, et al.
Publicado: (2014) -
The Molecular Mechanism of Human Voltage-Dependent Anion Channel 1 Blockade by the Metallofullerenol Gd@C(82)(OH)(22): An In Silico Study
por: Wang, Xiuxiu, et al.
Publicado: (2022) -
Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor
por: Liu, Ying, et al.
Publicado: (2015) -
Zeolite-Encaged Luminescent Silver Nanoclusters
por: Pan, Ling, et al.
Publicado: (2023)